Sharda Cropchem Ltd Q2 FY2027 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/u9dlt222dh1xwnafgzwxeadr.pdf

Key Takeaways


Volume Degrowth: The Quarter's Central Tension


Regional Divergence: NAFTA and LATAM Surge While Europe Pauses

Bubna: "We see this as a temporary weather-led impact rather than any change in underlying demand. Our registration portfolio and customer relationship in Europe remains strong."

Non-Agrochemical: A Sudden 68% Surge, With a Margin Caveat


Margins: Expansion Underway, H2 Uptick Expected


The Registration Moat: Unpredictable, Expensive, and Hard to Replicate

Bubna: "Sir, I have said in every conference call that the process of registration is absolutely unpredictable. And the things change at the last moment, the government authorities come out with new requirements at the last moment and the approval process also gets delayed because the authorities are not able to meet so frequently and many things which are totally beyond anybody's guesswork or planning. And this is what we are facing for the last 25 years."

Pricing, B2C and the Long-Term Bets

Bubna: "It is improving. The speed of improvement is still not as per our expectation, but it is improving. It is still far down compared to the pre-COVID days, but still, it is not impacting the general business so much."

Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growth10% to 15% YoYFY27
EBITDA margin18% to 20%FY27
H2 EBITDA marginUpwards of 20% (if lower end of full-year guidance holds)H2 FY27
Capex for registrations₹550 crores to ₹600 croresFY27
Europe recoveryRegion expected to do well; registration portfolio and customer relationships remain strongH2 FY27 (seasonally stronger period)
Volume recoveryMovement toward normality expected; uptick in demandH2 FY27 and FY28
Gross margin trajectoryExpected to hold or go upH2 FY27

Key Metrics

MetricQ2 FY27
Revenue₹1,052 cr, +13% YoY
Agrochemical revenue₹840 cr, +5% YoY
Non-agrochemical revenue₹212 cr, +68% YoY
Gross margin35.9%, expanded ~140 bps YoY from 34.5%
EBITDA₹164 cr, +18% YoY
EBITDA margin15.6%, up 70 bps YoY from 15%
PAT₹92 cr, +23% YoY
PBT prior to forex₹108 cr, +17% YoY on a like-to-like basis
Forex impactLoss of ₹0.4 cr, vs loss of ₹6.1 cr in Q2 FY26
Revenue growth bridge: price, forex, mix+18.3%, volume degrowth of -5.1%
FY27 revenue growth guidance10% to 15%
FY27 EBITDA margin guidance18% to 20%, supported by better product mix and operating leverage in H2
FY27 planned capex for registrations₹550 cr to ₹600 cr
Total product registrations3,044 as on 30 Sep 2026
Registration applications in pipeline946 as on 30 Sep 2026
Cash and bank liquid investments₹846 cr as on 30 Sep 2026
Working capital days70 days, improved by 28 days vs Mar 2026
ROCE25.9%
ROE20.1%
NAFTA region revenue growth~30% YoY, with significantly better margins
LATAM agrochemical revenue growthOver 80% YoY
Gross margin by geography: Europe41%
Gross margin by geography: NAFTA~40%
Gross margin by geography: LATAM14%
Gross margin by geography: Rest of World31%
H1 FY27 capex spent on registrations₹419 cr
Depreciation and amortization expense~₹100 cr in Q2 FY27, vs ₹70–75 cr in Q2 FY26